tiprankstipranks
Trending News
More News >
Verona Pharma Plc (VRNA)
NASDAQ:VRNA
US Market

Verona Pharma (VRNA) Technical Analysis

Compare
745 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is -1.99, suggesting Verona Pharma Plc is a Buy.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 59.49, while Verona Pharma Plc’s (VRNA) share price is $57.81, making it a Sell.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 59.47, while Verona Pharma Plc’s (VRNA) share price is $57.81, making it a Sell.

Verona Pharma (VRNA) Pivot Points

Apr 16, 2025, 05:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
50.76
52.22
54.97
56.43
59.18
60.64
63.39
Fibonacci
52.22
53.83
54.83
56.43
58.04
59.04
60.64
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Apr 16, 2025, 05:23 AM
Period
Simple
Exponential
MA5
56.31Buy
56.87Buy
MA10
56.67Buy
57.62Buy
MA20
60.86Sell
59.49Sell
MA50
62.61Sell
59.47Sell
MA100
53.86Buy
53.97Buy
MA200
40.82Buy
41.97Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 57.62, while Verona Pharma Plc’s (VRNA) share price is $57.81, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 53.97, while Verona Pharma Plc’s (VRNA) share price is $57.81, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $57.81 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 62.61, creating a Sell signal.
Verona Pharma Plc’s (VRNA) stock price is $57.81 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 53.86, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $57.81 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 40.82, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Apr 16, 2025, 05:23 AM
Name
Value
Implied Action
RSI (14)
45.77
Neutral
STOCH (9,6)
60.32
Neutral
STOCHRSI (14)
47.04
Neutral
MACD (12,26)
-1.99
Buy
ADX (14)
34.70
Neutral
Williams %R
-45.90
Buy
CCI (14)
-35.93
Neutral
ATR (14)
4.55
-
Ultimate Oscillator
60.73
Neutral
ROC
-12.65
Sell
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 45.77, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 34.70, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is -35.93, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is -12.65, creating a Sell signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 45.77, which suggests VRNA is a Neutral.
      What is VRNA’s MACD?
      VRNA’s MACD is -1.99, which suggests VRNA is a Buy.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 56.31, which suggests VRNA is a Buy.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 60.86, which suggests VRNA is a Sell.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 62.61, which suggests VRNA is a Sell.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 40.82, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -45.90, which suggests VRNA is a Buy.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is -35.93, which suggests VRNA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis